PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Ragon Institute study finds HIV-specific CD4 cells that control viral levels

Elevated expression of cell-death protein in individuals' CD4 T cells predicts rate of disease progression

2012-03-01
(Press-News.org) A subpopulation of the immune cells targeted by HIV may play an important role in controlling viral loads after initial infection, potentially helping to determine how quickly infection will progress. In the February 29 issue of Science Translational Medicine, a team of researchers from the Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard describe finding a population of HIV-specific CD4 T cells – cells traditionally thought to direct and support activities of other immune cells – that can directly kill HIV-infected cells.

"We observed the emergence of CD4 T cells able to kill HIV-infected cells in those patients who are able to control viral replication soon after acute infection," says Hendrik Streeck, MD, PhD, a Ragon Institute faculty member and senior author of the report. "These cells appear very early in HIV infection, and we believe they may set the stage for the course of the disease."

The primary role of CD4 T cells is to assist other cells of the immune system; and their importance is illustrated by how completely the immune response collapses after the cells, the main cellular targets of HIV, are destroyed. Ironically, CD4 cells that are specifically targeted against HIV are preferentially infected and depleted by the virus.

However, although HIV-specific CD4 cells have not been a major focus of vaccine research, these cells may have an important role in controlling HIV infection. "Every successful licensed vaccine induces CD4 T cell responses to some extent," Streeck explains, "and we know from many other viral infections that the success of the immune system in gaining control is best achieved in the presence of strong CD4 T cell responses."

To investigate whether CD4 T cell responses are important in the early control of HIV infection, the Ragon Institute team enrolled a group of 11 volunteers who were in the earliest stages of HIV infection, a time when viral levels are exceedingly high. A year into the study, participants were divided into two groups based on the level of HIV in their bodies – one group was able to keep HIV at low levels while the other group apparently had no immune control over HIV replication. Retrospective analysis of samples taken throughout the year showed striking differences in the CD4 T cell responses in both groups. While the HIV-specific CD4 responses in the group that did not control HIV replication quickly dropped and stayed low, the same response increased significantly in participants able to effectively control the virus, suggesting a role for HIV-specific CD4 cells in viral control.

Additional experiments revealed that the HIV-specific CD4 T cell responses showed activity associated with cell-killing and could even destroy HIV-infected macrophages – an unusual function for CD4 T cells, which have traditionally been seen as helper cells. In addition, the researchers determined that the presence of a specific cell-death protein called granzyme A prominently distinguished HIV-specific CD4 cells of participants maintaining a lower "viral set point" from those less able to control viral levels.

To validate these findings, the researchers examined a larger group of HIV-infected individuals and found that those with higher levels of granzyme A in their HIV-specific CD4 T cell response immediately after infection progressed more slowly to AIDS and did not require antiretroviral therapy as quickly as did those with lower levels of the protein. "The key baseline difference between these two groups has to do with the quality, not the quantity, of the HIV-specific CD4 T cell response," explains Streeck, an assistant professor of Medicine at Harvard Medical School. "In those who progressed to a lower viral set point, the early CD4 response was dominated by granzyme A expression, which was highly predictive of the rate of disease progression."

Associating a particular CD4 T cell activity with more successful suppression of viral levels suggests that inducing such responses with a vaccine may be beneficial, Streeck notes. In addition, the association of granzyme A expression with a more effective HIV-specific CD4 cell response suggests that measuring levels of the protein may allow prediction of disease outcome at the earliest stages of infection, something which is not currently possible. Future studies will need to explore the mechanisms underlying the cell-killing activities of the CD4 cell response and the functional and prognostic role of granzyme A.

###The lead author of the Science Translational Medicine report is Damien Soghoian of the Ragon Institute. Additional co-authors are Michael Flanders, Kailan Sierra-Davidson, Sam Butler, Thomas Pertel, PhD, Srinika Ranasinghe, PhD, Madelene Lindqvist, Isaiah Davis, Kimberly Lane, Alicja Piechocka-Trocha, Abraham Brass, MD, PhD, and Bruce Walker, MD, Ragon Institute of MGH, MIT and Harvard; Heiko Jessen, MD, Practice Jessen-Jesse-Stein, Berlin, Germany; Jenna Rychert, MD, and Eric Rosenberg, MD, MGH Infectious Disease Unit; and Jason Brenchley, PhD, National Institutes of Health. The study was funded by the National Institute for Allergy and Infectious Diseases of the National Institutes of Health

The Ragon Institute of MGH, MIT and Harvard was established in 2009 with a gift from the Phillip T. and Susan M. Ragon Foundation, creating a collaborative scientific mission among these institutions to harness the immune system to combat and cure human diseases. The primary initial focus of the institute is to contribute to the development of an effective AIDS vaccine. Administratively based at Massachusetts General Hospital, the Ragon Institute draws scientists and engineers from diverse backgrounds and areas of expertise across the Harvard and MIT communities and throughout the world, in order to apply the full arsenal of scientific knowledge to understanding mechanisms of immune control and immune failure and to apply these advances to directly benefit patients.


ELSE PRESS RELEASES FROM THIS DATE:

Observations refute widely held view on causal mechanism in ALS

Observations refute widely held view on causal mechanism in ALS
2012-03-01
In science, refuting a hypothesis can be as significant as proving one, all the more so in research aimed at elucidating how diseases proceed with a view toward preventing, treating, or curing them. Such a discovery can save scientists from spending precious years of effort exploring a dead end. In a study published in the Proceedings of the National Academy of Sciences, Munich-based researchers refute a widely accepted hypothesis about a causative step in neurodegenerative conditions. These results deal specifically with animal models of human amyotrophic lateral sclerosis ...

Healthe Trim, a Thermo-Energy Booster Dietary Supplement Arrives at GNC Stores

Healthe Trim, a Thermo-Energy Booster Dietary Supplement Arrives at GNC Stores
2012-03-01
Healthe Trim's proprietary blend of over 15 natural ingredients includes hoodia gordonii, a natural, time-tested appetite suppressant, green tea leaf extract that provides a natural energy boost and burns fat, and resveratrol, which is packed with antioxidants and increases the burning of nutrients and fat into energy. The natural health and wellness supplement company has expanded its presence into retail to meet the growing demand of customers nationwide who are looking to enhance their metabolism, curb their appetite and lose weight now. Healthe Trim founder Matthew ...

Cholera's nano-dagger

2012-03-01
Boston, MA (February 26, 2012)—Bacteria live in a state of perpetual warfare, with different species battling for dominion over their competitors and when pathogen, over their infected host. New research suggests that the human pathogen Vibrio cholerae, which causes the disease cholera, kills off its microbial rivals by jabbing them with a spring-loaded poison dagger. Were it not for that defense, called the Type 6 secretion system (T6SS), V. cholerae might not out-compete its neighbors to sicken millions of people every year. The results will be published online February ...

Study finds new genes that cause Baraitser-Winter syndrome, a brain malformation

2012-03-01
SEATTLE -- Scientists from Seattle Children's Research Institute and the University of Washington, in collaboration with the Genomic Disorders Group Nijmegen in the Netherlands, have identified two new genes that cause Baraitser-Winter syndrome, a rare brain malformation that is characterized by droopy eyelids and intellectual disabilities. "This new discovery brings the total number of genes identified with this type of brain defect to eight," said William Dobyns, MD, a geneticist at Seattle Children's Research Institute. Identification of the additional genes associated ...

New treatment using inhaled interferon may improve lung function in pulmonary fibrosis

New treatment using inhaled interferon may improve lung function in pulmonary fibrosis
2012-03-01
New Rochelle -- Inhaled interferon-gamma may be an effective treatment for idiopathic pulmonary fibrosis (IPF), a chronic and progressive form of lung disease caused by excessive formation of fibrotic, or scar tissue, in the lungs, according to an article published in Journal of Aerosol Medicine and Pulmonary Drug Delivery (http://www.liebertpub.com/jamp), a peer-reviewed journal from Mary Ann Liebert, Inc. (http://www.liebertpub.com) The article on inhaled interferon-gamma (http://online.liebertpub.com/doi/abs/10.1089/jamp.2011.0919) is available free online at the Journal ...

MedicalBillingSoftware.com Announces Update On Medisoft Medical Billing Software ANSI5010 Compliance and Adoption

2012-03-01
"Medisoft Medical Billing Software ANSI 5010 conversion is moving along smoothly," notes Harry Selent, CEO of www.MedicalBillingSoftware.com. Although the initial deadline for compliance has passed, the government has postponed enforcement of the adoption of the new standards to March 31, 2012 to allow time for both payers and doctors to fully comply. However, as more payers fully adopt the ANSI-5010 standards, doctors could see increased claim rejections from non-compliant claims. "Don't put your cash flow at risk" warns Selent. Verify that the latest ...

Effects of a concussion may last longer than symptoms, study shows

Effects of a concussion may last longer than symptoms, study shows
2012-03-01
LEXINGTON, Ky. -- A study recently published by the University of Kentucky's Scott Livingston shows that physiological problems stemming from a concussion may continue to present in the patient even after standard symptoms subside. Currently, concussions are diagnosed and monitored through a patient's self-reported symptoms (including headache, confusion or disorientation, poor concentration, and memory loss) and through computerized neuropsychological testing programs, which measure cognitive abilities including attention and concentration, cognitive processing, learning ...

Foresters UK Sponsors Wallace and Gromit 'Big Breakfast'

2012-03-01
Foresters are pleased to announce that they will be sponsoring Wallace and Gromits 'Big Breakfast' fundraising event from 20th - 27th April. Wallace & Gromit are calling on people across the UK to join The BIG Breakfast to raise thousands of pounds for sick children in hospitals and hospices by enjoying their BIG Breakfast. People from all walks of life are being invited to take part and host a 'Wallace & Gromit BIG Breakfast', from the 20th - 27th April. The fundraising event hopes to raise over GBP60,000. 'Wallace & Gromit's Children's Foundation is ...

Green schools and students' science scores are related

2012-03-01
A nationwide survey shows a positive correlation between Green School practices and student achievement in science. The study was conducted by the University of Colorado Denver's Department of Geography and Environmental Sciences. And presented Wednesday at the Green Schools National Network conference in Denver. Schools that took part in the survey observe GreenPrint core practices as defined by the Green Schools National Network (GSNN). The core practices are: Curriculum that advances environmental literacy and sustainability Stewardship and service learning Sustainable ...

Queen's professor urges health research to focus on the positive

2012-03-01
Political Studies professor Colin Farrelly wants to see more research into remarkable examples of health – such as why some people live 100 years disease-free. He describes the current pathology-based approach that emphasizes what causes specific diseases as "negative biology" and suggest more resources should be focused on "positive biology." "Currently the medical sciences presume that answering the question 'what causes disease?' is the most significant question to ask and answer," says Professor Farrelly. "Positive biology encourages us to invest just as much time, ...

LAST 30 PRESS RELEASES:

Program takes aim at drinking, unsafe sex, and sexual assault on college campuses

Inability to pay for healthcare reaches record high in U.S.

Science ‘storytelling’ urgently needed amid climate and biodiversity crisis

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy

How VR technology is changing the game for Alzheimer’s disease

A borrowed bacterial gene allowed some marine diatoms to live on a seaweed diet

Balance between two competing nerve proteins deters symptoms of autism in mice

Use of antifungals in agriculture may increase resistance in an infectious yeast

Awareness grows of cancer risk from alcohol consumption, survey finds

The experts that can outsmart optical illusions

Pregnancy may reduce long COVID risk

Scientists uncover novel immune mechanism in wheat tandem kinase

Three University of Virginia Engineering faculty elected as AAAS Fellows

[Press-News.org] Ragon Institute study finds HIV-specific CD4 cells that control viral levels
Elevated expression of cell-death protein in individuals' CD4 T cells predicts rate of disease progression